DAVITA INC. Most Important Performance Measures
The measures each proxy statement lists as most important for linking pay to performance (Item 402(v) tabular list), as tagged, newest proxy first.
- 2023-04-25: Measure Adjusted Earnings per Share.
- 2023-04-25: Measure Free cash flow from continuing operations.
- 2023-04-25: Measure Consolidated adjusted operating income.
- 2023-04-25: Measure Total shareholder return.
| Proxy filed | Measure |
|---|---|
| 2023-04-25 | Adjusted Earnings per Share |
| 2023-04-25 | Free cash flow from continuing operations |
| 2023-04-25 | Consolidated adjusted operating income |
| 2023-04-25 | Total shareholder return |
| 2024-04-26 | Adjusted Earnings per Share |
| 2024-04-26 | Free cash flow from continuing operations |
| 2024-04-26 | Consolidated adjusted operating income |
| 2024-04-26 | Total shareholder return |
| 2025-04-24 | Adjusted Earnings per Share |
| 2025-04-24 | Free cash flow from continuing operations |
| 2025-04-24 | Consolidated adjusted operating income |
| 2025-04-24 | Total shareholder return |
| 2026-04-22 | Adjusted Earnings per Share |
| 2026-04-22 | Free cash flow |
| 2026-04-22 | Adjusted operating income |
| 2026-04-22 | Total shareholder return |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |